12 Health Care Stocks Moving In Friday's After-Market Session

Gainers

  • Ocular Therapeutix OCUL shares moved upwards by 12.3% to $4.01 during Friday's after-market session. The company's market cap stands at $307.7 million.
  • BioLine Rx BLRX shares increased by 12.29% to $1.37. The market value of their outstanding shares is at $65.3 million.
  • Cabaletta Bio CABA stock increased by 10.14% to $1.52. The market value of their outstanding shares is at $44.0 million.
  • Jasper Therapeutics JSPR shares increased by 8.52% to $3.31. The market value of their outstanding shares is at $125.3 million.
  • Chembio Diagnostics CEMI stock moved upwards by 7.69% to $0.62. The company's market cap stands at $18.7 million.
  • Allena Pharma ALNA stock rose 7.62% to $0.17. The market value of their outstanding shares is at $15.7 million.

Losers

  • First Wave BioPharma FWBI shares declined by 34.0% to $0.41 during Friday's after-market session. This security traded at a volume of 640.9K shares come close, making up 78.8% of its average volume over the last 100 days. The market value of their outstanding shares is at $6.8 million.
  • NeoGenomics NEO stock fell 9.32% to $8.57. The company's market cap stands at $1.0 billion. The company's, Q1 earnings came out 2 days ago.
  • Aclarion ACON shares fell 7.73% to $1.91. The company's market cap stands at $14.9 million.
  • Zynerba Pharmaceuticals ZYNE shares decreased by 5.68% to $1.33. The market value of their outstanding shares is at $58.0 million.
  • Syndax Pharmaceuticals SNDX stock fell 5.67% to $15.82. The company's market cap stands at $870.3 million.
  • Midatech Pharma MTP stock fell 4.77% to $0.62. The company's market cap stands at $12.2 million. See Also: www.benzinga.com/money/best-healthcare-stocks/

This article was generated by Benzinga's automated content engine and reviewed by an editor.

Market News and Data brought to you by Benzinga APIs
Comments
Loading...
Posted In: MoversBZI-TFM
Benzinga simplifies the market for smarter investing

Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.

Join Now: Free!